Publication | Open Access
Early phase clinical studies of <scp>AR</scp>‐42, a histone deacetylase inhibitor, for neurofibromatosis type 2‐associated vestibular schwannomas and meningiomas
36
Citations
46
References
2021
Year
1b, 4.
| Year | Citations | |
|---|---|---|
Page 1
Page 1